Literature DB >> 19303342

Late Mycobacterium bovis spondylitis after intravesical BCG therapy.

Andreas F Mavrogenis1, Vasileios I Sakellariou, Sotirios Tsiodras, Panayiotis J Papagelopoulos.   

Abstract

A 72-year-old man presented with a 6-month history of low back and leg pain. Past medical history revealed transurethral resection of bladder cancer followed by multiple intravesical BCG instillation 12 years ago. Imaging studies of the thoracolumbar spine showed osteolysis of the L3 and L4 vertebrae and the associated intervertebral disc space, and a large soft tissue mass with signal abnormalities suggesting of an abscess. CT-guided needle biopsy showed Mycobacterium bovis infection. A triple anti-tuberculous chemotherapy regimen including isoniazid, rifampicin, and ethambutol was administered for 12 months. Surgical treatment included drainage of the abscess and L2-L5 spinal instrumentation and fusion. Intravesical BCG therapy may be complicated by late disseminated disease to the bone even many years after initial BCG therapy. Patients having BCG therapy should be closely evaluated thereafter for the possibility of hematogenous spread of mycobacteria to distant sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303342     DOI: 10.1016/j.jbspin.2008.10.011

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  14 in total

1.  A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  Colin B Josephson; Saleh Al-Azri; Daniel J Smyth; David Haase; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.

Authors:  Ine M Westhovens; Marie-Elena Vanden Abeele; Peter E Messiaen; Jeroen Ch van der Hilst
Journal:  BMJ Case Rep       Date:  2016-05-11

3.  Post-intravesical BCG epididymo-orchitis: Case report and a review of the literature.

Authors:  S G Parker; S S Kommu
Journal:  Int J Surg Case Rep       Date:  2013-06-14

Review 4.  Bone and joint tuberculosis.

Authors:  Carlos Pigrau-Serrallach; Dolores Rodríguez-Pardo
Journal:  Eur Spine J       Date:  2012-06-19       Impact factor: 3.134

5.  Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment.

Authors:  Bart Santbergen; P H W E Vriens; W C M de Lange; M E E Van Kasteren
Journal:  BMJ Case Rep       Date:  2013-01-25

6.  Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer.

Authors:  Hanish Jain; Kunal Gada; Syed Zaidi; Elizabeth Asiago-Reddy; Ambika Eranki
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-12

7.  Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.

Authors:  Sami Obaid; Alexander G Weil; Ralph Rahme; Cathy Gendron; Daniel Shedid
Journal:  Surg Neurol Int       Date:  2011-11-14

8.  Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer.

Authors:  Charles E Mackel; Shane M Burke; Taylor Huhta; Ron Riesenburger; Simcha J Weller
Journal:  Cureus       Date:  2016-03-26

Review 9.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

10.  Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer.

Authors:  Masashi Miyazaki; Toyomi Yoshiiwa; Toshinobu Ishihara; Masanori Kawano; Hiroshi Tsumura
Journal:  Case Rep Orthop       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.